Stocks and Investing Stocks and Investing
Mon, April 22, 2024

Vikram Purohit Maintained (ASND) at Hold and Held Target at $116 on, Apr 22nd, 2024


Published on 2024-10-28 10:31:18 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $116 on, Apr 22nd, 2024.

Vikram has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Vikram


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Thursday, April 18th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $167 on, Tuesday, April 2nd, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024

Contributing Sources